Winter illnesses are slamming the U.S. A mutant influenza variant is sending scores of people to hospitals, 32 children have ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...

Enanta’s portfolio of RSV replication inhibitors with potential for first-in-disease and best-in-disease treatment.

According to a new study, respiratory syncytial virus (RSV) is a major contributor to infant admissions into the hospital.

Nirsevimab exhibited a greater reduction in RSV-related hospitalization risk for infants compared with maternal RSVpreF vaccination.

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around ...

About The Study: In adults age 60 or older, all-cause cardiorespiratory hospitalization was significantly lower with respiratory syncytial virus (RSV) prefusion F protein than with no vaccine. The ...

Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...

A new study published in the Journal of American Medical Association showed that veterans, 60 years of age and older who got ...

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (ENTA) (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and ...